Q2 Sales up 33% year-over-year & First Half 2019 sales up 45% year-over-year. Consumables sales represent the largest driver of growth in both...
Mauna Kea Technologies Reports Second Quarter and First Half 2019 Sales
read more
Search Results
Receipt of €11.5 Million Under New Financing Agreement with the European Investment Bank
Mauna Kea Technologies announces today that it has received the first tranche of €11.5 million (Tranche 1), under a financing agreement...
Signing of a 22.5 Million Euros Loan Agreement with the European Investment Bank (EIB)
Mauna Kea Technologies and the European Investment Bank (EIB), which is the Bank of the European Union (EU), announce the signing of a 22.5 million...
Reimbursement Coverage in France for the use of Confocal Laser Endomicroscopy for Barrett’s Esophagus
Announcement of the creation of a new specific procedural code to be added to the Common Classification of Medical Procedures (CCAM) published in...
Mauna Kea Technologies announces the exercise of a tranche of €5 million debt with IPF Partners
Mauna Kea Technologies today announced the exercise of a tranche of €5 million with IPF Partners, as part of the amendment of the Debt...
17 Presentations Highlighting the Clinical Value of Cellvizio® in Gastrointestinal Diseases at the Digestive Disease Week® 2019
17 accepted abstracts demonstrate growing clinical recognition of Cellvizio® as a necessary tool for real-time endomicroscopy imaging in...
Positive Results on Needle-Based Endomicroscopy for Real-Time Diagnosis and Staging of Lung Cancer
Clinical study results published in the European Respiratory Journal demonstrate that lung cancer characteristics can be accurately recognized with...
Mauna Kea Technologies Reports First Quarter 2019 Sales
READ THE COMPLETE PRESS RELEASE
Financial results for the full year ended December 31, 2018
READ THE COMPLETE PRESS RELEASE
Mauna Kea Technologies to Announce 2018 Full Year Results on March 20, 2019
READ THE COMPLETE PRESS RELEASE
510(k) Clearance for the Cellvizio® Needle-Based AQ-Flex 19 Confocal Miniprobe Enabling Peripheral Lung Nodule Targeting and Imaging
The Cellvizio® AQ-Flex probe is cleared for use with transbronchial needles through existing bronchoscopes and bronchoscopic accessories Mauna...
Mauna Kea Technologies Provides An Update On Its Commercial Partnership Agreement For Urological Applications
Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy...